News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
6 | Follower
Cohort study finds lithium to be the only monotherapy that decreased the chances of depression-related hospitalisation in people with bipolar disorder.
Kirsten Lawson and Douglas Badenoch review the new randomised controlled trial by Cleare et al, published today in The Lancet Psychiatry, directly comparing the clinical and cost effectiveness of lithium and quetiapine as augmentation treatments for patients with 'treatment resistant depression'.
Dhea Bendargi summarises a Delphi study that involved lived experience and researcher stakeholders in developing a comprehensive set of guidelines for involving youth with lived and living experience of suicide in suicide research.